Highly Commended, BMA Medical Book Awards 2014
Chronic myeloid leukemia is a clonal disease that results from an acquired genetic change in a single pluripotential hemopoietic stem cell. Efforts to confront this disease have been assisted by advances in cellular and molecular biology and the speed at which these findings have transformed the therapeutic algorithm. Nevertheless, there is some uncertainty with regards to how best to assess efficacy of treatment, especially with regards to the most appropriate surrogate markers for overall survival. From the standpoint of biology and clinical management, this handbook provides an authoritative state-of-the-art review of current and developing progress.
- ISBN:
- 9781842145777
- 9781842145777
-
Category:
- Oncology
- Format:
- Paperback
- Publication Date:
-
25-04-2013
- Language:
- English
- Publisher:
- Taylor & Francis Ltd
- Country of origin:
- United Kingdom
- Pages:
- 152
- Dimensions (mm):
- 198x129x9mm
- Weight:
- 0.28kg
Our Australian supplier has this title on order. You can place a backorder for this title now and we will ship it to you when it becomes available.
While we are unable to provide a delivery estimate, most backorders will be delivered within 120 days. If we are informed by our supplier that the title is no longer available during this time, we will cancel and refund you for this item. Likewise, if no delivery estimate has been provided within 120 days, we will contact our supplier for an update. If there is still no delivery estimate we will then cancel the item and provided you with a refund.
If we are able to secure you a copy of the title, our supplier will despatch it to our Sydney warehouse. Once received we make sure it is in perfect condition and then despatch it to you via the Australia Post eParcel service, which includes online tracking. You will receive a shipping notice from us when this occurs.
Share This Book: